Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 1.00 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 1.00 |
| ▸ | S1PR2 | O95136 | 11/20 | 0.68 |
| ▸ | S1PR1 | P21453 | 11/20 | 0.68 |
| ▸ | S1PR3 | Q99500 | 11/20 | 0.68 |
| ▸ | S1PR4 | O95977 | 9/20 | 0.68 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.68 |
| ▸ | TYMS | P04818 | 1/20 | 0.58 |
| ▸ | FDPS | P14324 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL307332 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL107866 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL194178 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL35167 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL22722948 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL23534144 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL33472 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL337384 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL939248 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 | |
| SCHEMBL19906 | 1.00 | LPAR3 (1.00) | LPAR3LPAR2S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312523-B2 | Quantum dot light emitting device and method for preparing the same, and quantum dot display device | Beijing Boe Technology Development Co., Ltd. (CN) | 2025-05-27 | — | — | US | claimed |
| US-20220085312-A1 | QUANTUM DOT LIGHT EMITTING DEVICE AND METHOD FOR PREPARING THE SAME, AND QUANTUM DOT DISPLAY DEVICE | Beijing Boe Technology Development Co., Ltd. (CN) | 2022-03-17 | — | — | US | claimed |
| US-9976037-B2 | Composition for treating surface of substrate, method and device | VERSUM MATERIALS US, LLC (US) | 2018-05-22 | — | — | US | claimed |
| US-20160289455-A1 | Composition for Treating Surface of Substrate, Method and Device | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-10-06 | — | — | US | claimed |
| WO-2016161289-A1 | COMPOSITION FOR TREATING SURFACE OF SUBSTRATE, METHOD AND DEVICE | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-10-06 | — | — | WO | claimed |
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | SEIKO EPSON CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4725714-A1 | IDENTIFICATION ELEMENT, INQUIRY DEVICE, AND INQUIRY METHOD | Sony Group Corporation (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4316859-B1 | DRAWING SYSTEM AND DRAWING METHOD | SONY GROUP CORP (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-12466196-B2 | Drawing system and drawing method | Sony Group Corporation (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250229560-A1 | DRAWING OBJECT AND METHOD OF FORMING DRAWING OBJECT | Sony Group Corporation (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12312523-B2 | Quantum dot light emitting device and method for preparing the same, and quantum dot display device | Beijing Boe Technology Development Co., Ltd. (CN) | 2025-05-27 | — | — | US | disclosed |
| WO-2025052861-A1 | DRAWING METHOD AND DRAWING SYSTEM | ソニーグループ株式会社 | 2025-03-13 | — | — | WO | disclosed |
| US-5296439-A | Support with reversible thermosensitive coloring recording layer containing electron donor coloring compound, electron acceptor which reacts to induce color formation | RICOH COMPANY, LTD. (JP) | 1994-03-22 | — | — | US | disclosed |
| EP-0576015-A1 | Method of reversible recording | Ricoh Company, Ltd (JP) | 1993-12-29 | — | — | EP | disclosed |
| US-5155099-A | ALKYLPHOSPHONOSERINES AND PHARMACEUTICAL COMPOSITIONS USEFUL AS CYTOSTATIC AGENTS | HAFSLUND NYCOMED PHARMA AKTIENGESELLSCHAFT (AT) | 1992-10-13 | — | — | US | disclosed |
| EP-0492628-A1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | Ricoh Company, Ltd (JP) | 1992-07-01 | — | — | EP | disclosed |
| US-4280960-A | Phosphonic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-28 | — | — | US | disclosed |
| US-4225474-A | Organophosphonate coester stabilizers | ARGUS CHEMICAL CORP. (US) | 1980-09-30 | — | — | US | disclosed |
| US-4195035-A | Alkane-bisalkyl-phosphinic anhydrides and process for the manufacture of alkane-phosphonic anhydrides and alkane-bis alkyl-phosphinic anhydrides | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-03-25 | — | — | US | disclosed |
| EP-0006842-A1 | Organophosphonate co-ester, stabiliser composition containing it and synthetic resin stabilised therewith | S.A. Diamond Shamrock Benelux N.V. (BE) | 1980-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | HAO2, PHOSPHO1, HAO1 | LPAR3 768/4885LPAR2 722/4885S1PR2 1377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.